Urge members of the House Population Health Subcommittee to SUPPORT HB 1852 that would prohibit the administration of mRNA vaccines and injectable solutions in Tennessee, emphasizing medical freedom and state sovereignty over federal regulations.

The Tennessee mRNA Pharmaceutical Sovereignty and Safety Act would ban any person or professional—including physicians, nurses, pharmacists, veterinarians and allied healthcare providers—from administering or dispensing any vaccine or injectable solution that contains mRNA technology or mRNA-derived components. The measure spans eight separate code titles—ranging from mental health (Title 33) to public health (Title 68)—ensuring no medical or veterinary licensee may use, prescribe, or inject an mRNA-based product. Supporters argue this responds to reported adverse events, alleged biodistribution risks, and perceived long-term unknowns of mRNA interventions.

By invoking the state’s police power under the Tenth Amendment, the bill asserts Tennessee’s right to regulate healthcare independent of FDA approvals or CDC guidance. It emphasizes medical freedom for patients and practitioners to refuse or avoid mRNA shots and rejects any federal or private mandate compelling their use. The act frames itself as a protective response to what it calls “widespread and severe adverse events,” covering cardiovascular harms, neurological disorders, reproductive concerns, and even environmental risks posed by self-amplifying mRNA in agriculture.

Proponents highlight alternative treatments—such as ivermectin, hydroxychloroquine, monoclonal antibodies and inhaled steroids—as safe, affordable, and often sidelined by federal agencies. By outlawing mRNA injections, Tennessee legislates a healthcare exception zone where mRNA products carry neither liability protection nor lawful licensure. The measure thus dovetails with broader “medical sovereignty” efforts to block federal vaccine mandates and preserve practitioner discretion and patient choice.

Critics will warn of bureaucratic enforcement challenges, potential conflicts with federal preemption doctrines, and the impact on routine immunizations (e.g., influenza) if manufacturers pivot to mRNA platforms. Nonetheless, supporters argue that unchecked federal agency power over healthcare transcends constitutional bounds and that states must refuse to enable what they view as untested, risky technology.

We strongly SUPPORT this bill and ask that you contact the members of the House Population Health Subcommittee to vote YES on HB 1852.

Use the form below to contact members of the House Population Health Subcommittee.

Please be respectful in your communications. You are advocating for a position on a particular issue. This is not personal. And sometimes, your legislator is already on your side.

Use this tool to communicate via email. Please note that you may edit the content of the message. It is important to personalize messages as much as you are able. Your physical address is required so that we may connect you with the appropriate elected representative. THIS FORM IS FOR RESIDENTS OF THE STATE OF TENNESSEE ONLY.